Guillaume Köszegi
About Guillaume Köszegi
Guillaume Köszegi is the Head of CAR T Marketing for Lymphoma and Myeloma at Bristol Myers Squibb in Canada, with over 18 years of experience in Hematology Oncology.
Title at Bristol Myers Squibb
Guillaume Köszegi currently holds the position of Head of CAR T Marketing, Lymphoma, and Myeloma at Bristol Myers Squibb in Canada. He oversees marketing strategies and operations specifically targeting lymphoma and myeloma therapies.
Previous Roles at Bristol Myers Squibb
Before becoming the Head of CAR T Marketing, Guillaume served as the Senior CAR T Site Leader for National Commercial Operations at Bristol Myers Squibb. He held this role from 2019 to 2020, based in Montreal, Quebec, Canada.
Employment History at Celgene
Guillaume Köszegi has a multifaceted history with Celgene, holding several important roles over the years. From 2018 to 2019, he worked as a Senior Manager in National Patient Access for Market Access. Prior to that, he served as the Myeloma Pipeline Commercial Lead from 2017 to 2018. From 2011 to 2017, he was the Regional Sales Manager in the Montreal, Canada area, and he began his tenure at Celgene as a Therapeutic Development Specialist from 2007 to 2011.
Previous Experience in Oncology
Guillaume's oncology experience includes working at Bayer Pharmaceuticals as an Oncology Therapeutic Specialist from 2006 to 2007. He also worked at Berlex Canada Inc as a Specialist Representative in Oncology from 2003 to 2006. His career in medical sales began with a position at AstraZeneca, where he served as a Medical Sales Representative from 2001 to 2003.
Education
Guillaume Köszegi studied at Concordia University, where he earned a Bachelor of Arts (BA) in Economics.
Experience in Hematology Oncology
With over 18 years of experience specifically in hematology oncology, Guillaume has played a key role in the successful launch of multiple novel therapies. His extensive background encompasses leadership in Sales Management, Marketing, Market Access, and CAR-T Operations.
Leadership in CAR T Operations
Guillaume Köszegi has been responsible for launching the Bristol Myers Squibb CAR T franchise in Canada since December 2020. His expertise is recognized for leadership and executional excellence in strategic roles within the niche of hematology oncology.